Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,582Revenue $M934Net Margin (%)-5.6Z-Score1.7
Enterprise Value $M10,985EPS $2.2Operating Margin %1.9F-Score5
P/E(ttm))0Cash Flow Per Share $3.6Pre-tax Margin (%)-8.6Higher ROA y-yN
Price/Book19.010-y EBITDA Growth Rate %0Quick Ratio0.8Cash flow > EarningsY
Price/Sales7.75-y EBITDA Growth Rate %0Current Ratio0.9Lower Leverage y-yY
Price/Cash Flow11.8y-y EBITDA Growth Rate %-30.0ROA % (ttm)-2.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-11.3Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M63.7ROI % (ttm)2.6Gross Margin Increase y-yN

Gurus Latest Trades with SLXP

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SLXPJohn Paulson 2014-12-31 Buy 3.4%$91.47 - $152.87
($120.33)
$ 157.231%New holding, 5806000 sh.5,806,000
SLXPGeorge Soros 2014-12-31 Buy 0.62%$91.47 - $152.87
($120.33)
$ 157.231%New holding, 491531 sh.491,531
SLXPVanguard Health Care Fund 2014-12-31 Sold Out -0.61%$91.47 - $152.87
($120.73)
$ 157.230%Sold Out0
SLXPAndreas Halvorsen 2014-12-31 Reduce-0.61%$91.47 - $152.87
($120.33)
$ 157.231%Reduce -36.09%1,738,104
SLXPAndreas Halvorsen 2014-06-30 Add0.74%$97.7 - $125.07
($110.33)
$ 157.242%Add 86.19%2,889,303
SLXPJoel Greenblatt 2014-06-30 Sold Out -0.48%$97.7 - $125.07
($110.33)
$ 157.242%Sold Out0
SLXPAndreas Halvorsen 2014-03-31 Buy 0.67%$88.8 - $114.64
($101.95)
$ 157.254%New holding, 1551766 sh.1,551,766
SLXPJoel Greenblatt 2014-03-31 Buy 0.48%$88.8 - $114.64
($101.95)
$ 157.254%New holding, 307445 sh.307,445
SLXPJoel Greenblatt 2013-09-30 Sold Out -0.36%$65.73 - $75.54
($68.97)
$ 157.2128%Sold Out0
SLXPJoel Greenblatt 2013-06-30 Buy 0.36%$47.72 - $66.83
($57.19)
$ 157.2175%New holding, 127495 sh.127,495
SLXPVanguard Health Care Fund 2013-03-31 Add0.08%$40.472 - $51.37
($47.96)
$ 157.2228%Add 22.44%2,147,945
SLXPJoel Greenblatt 2013-03-31 Sold Out -0.15%$40.472 - $51.37
($47.96)
$ 157.2228%Sold Out0
SLXPJoel Greenblatt 2012-12-31 Add0.06%$37.97 - $42.9
($40.82)
$ 157.2285%Add 75.81%63,399
SLXPNWQ Managers 2012-12-31 Sold Out -0.17%$37.97 - $42.9
($40.82)
$ 157.2285%Sold Out0
SLXPJoel Greenblatt 2012-09-30 Buy 0.1%$41.92 - $55.65
($47.44)
$ 157.2231%New holding, 36061 sh.36,061
SLXPNWQ Managers 2012-03-31 Reduce-0.14%$45.72 - $53.75
($46.12)
$ 157.2241%Reduce -40.33%656,533
SLXPNWQ Managers 2011-09-30 Add0.18%$26.18 - $40.9
($33.07)
$ 157.2375%Add 198.07%1,320,679
SLXPVanguard Health Care Fund 2011-09-30 Add0.09%$26.18 - $40.9
($33.07)
$ 157.2375%Add 55.43%1,554,300
SLXPJohn Paulson 2011-09-30 Sold Out -0.2056%$26.18 - $40.9
($33.07)
$ 157.2375%Sold Out0
SLXPJohn Paulson 2011-06-30 Add0.19%$34.69 - $40.57
($37.85)
$ 157.2315%Add 971.43%1,500,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SLXP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SLXP John Paulson 2014-12-315,806,0009.113.4New Buy
SLXP George Soros 2014-12-31491,5310.770.62New Buy
SLXP Andreas Halvorsen 2014-12-311,738,1042.730.92-36.09%
SLXP Vanguard Health Care Fund 2014-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


SLXP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Forbes William PEVP Research&Devel & CDO 2014-11-12Sell11,079$95.0565.12view
CREECH TIMOTHY JSee Remarks 2014-11-05Sell0$065.12view
LOGAN CAROLYN JPresident & CEO 2014-06-26Sell53,057$123.3827.21view
Scruggs Rick DExecutive Vice President 2014-05-16Sell900$105.6748.53view
D ALONZO THOMASDirector 2014-04-22Sell11,530$110.8941.54view
Scruggs Rick DExecutive Vice President 2014-03-04Sell1,319$110.6641.83view
CHAPPELL JOHN FDirector 2014-03-04Sell10,000$112.239.88view
D ALONZO THOMASDirector 2014-01-10Sell12,050$91.8370.91view
DERBYSHIRE ADAM CEVP Finance/CFO 2014-01-09Sell30,001$91.4871.57view
Forbes William PEVP Research&Devel & CDO 2014-01-08Sell8,000$90.0674.27view

Press Releases about SLXP :

Quarterly/Annual Reports about SLXP:

News about SLXP:

Articles On GuruFocus.com
Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals Feb 24 2015 
John Paulson's Top Buys Feb 21 2015 
John Paulson Chooses Energy, Semiconductor and Drug Stocks in Q4 Feb 19 2015 
Fourth-Quarter Acquisitions Rearrange Jana Partners’ Portfolio Feb 18 2015 
Three Pharma Majors In The Run To Acquire Salix Feb 16 2015 
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Salix Pharmaceu Dec 12 2014 
Pharmaceutical Giant Merck Buys Cubist Pharma Dec 09 2014 
Bill Ackman and Valeant Could Sweeten Allergan Deal By $15 A Share Oct 10 2014 
Steven Cohen Has a Track Record of Impressive Returns Jul 31 2014 
Joel Greenblatt's Gotham Capital Top 5 New Stocks May 16 2014 

More From Our Partners
Stock Market News for February 24, 2015 - Market News Feb 24 2015 - ZACKS

More From Other Websites
Basics of the Salix–Valeant merger transaction Feb 26 2015
SALIX PHARMACEUTICALS, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of... Feb 26 2015
JANA opens new position in Salix Pharmaceuticals Feb 26 2015
The Salix–Valeant merger will follow a cash tender timeline Feb 26 2015
Jazz Pharmaceuticals Tops Q4 Earnings And Tests Buy Point Feb 26 2015
Salix Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 1.5%... Feb 26 2015
Salix Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 2.75%... Feb 25 2015
Salix Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 2.75%... Feb 25 2015
Salix Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 1.5%... Feb 25 2015
Lifshitz & Miller Law Firm Announces Investigation of Bridgepoint Education, Inc., Globe Specialty... Feb 25 2015
Law Offices of Marc S. Henzel Announces Securities Class Action Periods Feb 25 2015
Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash Feb 25 2015
UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors... Feb 24 2015
Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of Salix Pharmaceuticals, Ltd. Feb 24 2015
Salix Pharmaceuticals (SLXP) Stock Price Target Increased Today at Cantor Fitzgerald Feb 24 2015
Ryan & Maniskas, LLP Announces Investigation of Salix Pharmaceuticals Ltd. Feb 24 2015
Stock Market News for February 24, 2015 - Market News Feb 24 2015
Valeant Pharmaceuticals (VRX) Earnings Report: Q4 2014 Conference Call Transcript Feb 24 2015
Pharma ETFs in Focus on Valeant-Salix Deal - ETF News And Commentary Feb 24 2015
Princely Sums Weigh on Valeant Feb 24 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK